Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-26

Clinical Trial Update: Emp-Activity: Empagliflozin Functional Capacity

View source ↗

Summary

The Emp-Activity trial evaluating empagliflozin's impact on functional capacity in heart failure has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empagliflozin (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Heart Failure | Status: COMPLETED | Results posted: 2025-08-26